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Abstract
Objective
This study evaluated maternal C-reactive protein (CRP) as a predictor of microbial invasion
of the amniotic cavity (MIAC) and histological chorioamnionitis (HCA) in women with pre-
term prelabor rupture of the membranes (PPROM) before and after 32 weeks of gestation.
Methods
This study was a prospective observational cohort study of 386 women. Maternal serum
CRP concentrations were evaluated, and amniotic fluid samples were obtained via transab-
dominal amniocentesis at the time of admission. Placentas underwent histopathological
examination after delivery. MIAC was defined based on a positive PCR for Ureaplasma spe-
cies,Mycoplasma hominis and Chlamydia trachomatis and/or positive 16S rRNA gene
amplification. HCA was defined based on the Salafia classification.
Results
Maternal CRP was significantly higher in women with MIAC and HCA (median 9.0 mg/l)
than in women with HCA alone (median 6.9 mg/l), MIAC alone (median 7.4 mg/l) and with-
out MIAC or HCA (median 4.5 mg/l) (p<0.0001). CRP was a weak predictor of the occur-
rence of MIAC and HCA before and after 32 weeks of gestation. Only the 95th percentile of
CRP and PPROM before 32 weeks exhibited a false-positive rate of 1%, a positive predic-
tive value of 90% and a positive likelihood ratio of 13.2 to predict MIAC and HCA. However,
the low sensitivity of 15% limits the clinical utility of this detection.
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Conclusion
CRP is a poor predictor of the occurrence of MIAC and HCA, even at early gestational ages.
Introduction
Preterm delivery is a worldwide public health problem, and it occurs in approximately 6–12%
of all pregnancies [1]. Preterm prelabor rupture of membranes (PPROM) is defined as amni-
otic fluid leakage before 37 weeks of gestation, and it represents approximately 30–40% of all
preterm deliveries. PPROM is responsible for a substantial proportion of adverse neonatal
complications associated with gestational age and risk of infection [2, 3].
Microbial invasion of the amniotic cavity (MIAC) is identified in 30–40% of PPROM, par-
ticularly at early gestational ages [4]. The presence of microorganisms activates an inflamma-
tory response in the amniotic cavity, which is associated with early gestational age at delivery
and a shorter latency to delivery [5].
Signs of histological chorioamnionitis (HCA) are also observed after placental examination
in up to 60% of all preterm deliveries [6, 7]. HCA and funisitis are associated with neonatal
composite morbidity, including chronic pulmonary disease [8] and adverse neurodevelopment
outcomes [9, 10].
The active management of PPROM in the Czech Republic provides a short latency from
membrane rupture to delivery in women with a PPROM diagnosis. This management scheme
provides unique information on the subgroup of women presenting MIAC and HCA. We pre-
viously demonstrated that women with MIAC and HCA exhibited the greatest intra-amniotic
inflammation [11, 12]. Similar results were observed in the fetal inflammatory response in the
umbilical cord using interleukin (IL)-6 assessments[13]. Pregnancies complicated with MIAC
and HCA exhibit the highest incidence of the subsequent development of early onset sepsis in
newborns [14]. Notably, no differences were observed in the inflammatory responses in the
amniotic cavity or fetal compartment in women with HCA or MIAC alone compared to a neg-
ative infectious group. Previous data suggest that the presence of MIAC and HCA represents
the worse infectious scenario associated with the earliest gestational age at PPROM and the
highest inflammatory response in amniotic fluid and umbilical cord. Therefore, the antenatal
prediction of women with MIAC and HCA is crucial to improve the clinical management of
women presenting with PPROM.
The only method to diagnose MIAC involves an invasive procedure, and placental informa-
tion on HCA is not available antenatally. Therefore, non-invasive approaches were widely pro-
posed (e.g., in maternal serum, cervico-vaginal fluid or ultrasound evaluations of the cervix
and fetus [15–19]) to identify MIAC or HCA.
Evaluation of 27 biomarkers using a multiplex approach revealed differences in the concen-
tration of IL-18, IL-1β and monocyte chemotactic protein-1 (MCP-1) in maternal serum
between PPROM women with or without MIAC. Notably, these differences were only observed
prior to 32 weeks of gestation [20]. However, this multiplex approach did not consider CRP in
the analysis.
Maternal serum CRP has been proposed as a marker of infection and inflammation in sev-
eral diseases [21–23] and MIAC and HCA. CRP exhibits a weak and contradictory association
with these two conditions [19, 24, 25]. Howman et al. observed a significantly higher maternal
inflammatory response when evaluating CRP in women with HCA [26]. However, a systematic
review by Martinez et al. concluded that there was no evidence to support the use of CRP as a
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tool for the prediction of HCA [19]. No significant differences were reported when CRP levels
were compared between PPROM women with or without MIAC [24]. To our knowledge, there
are no previous studies evaluating the role of maternal CRP based on the presence of MIAC
and HCA, HCA alone, MIAC alone and a negative infectious group.
It is clinically important to evaluate the role of CRP as a predictor of the worst infectious
conditions, such as the occurrence of MIAC and HCA, because the information for maternal
CRP associated with infection might induce changes in the management of PPROM in most
clinical settings. Whether gestational age influences the predictive value of CRP for infectious
conditions should also be investigated.
Therefore, the present study evaluated maternal CRP as a predictor of MIAC and HCA in
women with PPROM before and after 32 weeks of gestation.
Materials and Methods
This study was conducted as an observational prospective cohort study. The individuals
enrolled in this study were pregnant women with PPROM between gestational ages 24+0 and
36+6 weeks who were admitted to the Department of Obstetrics and Gynecology, University
Hospital Hradec Kralove, Czech Republic from January 2008 to December 2013. Gestational
age was established based on the first trimester ultrasound scan.
Inclusion criteria were singleton pregnancies and maternal age 18 years. Women with
signs of clinical chorioamnionitis, fetuses with an estimated weight<10th percentile, the pres-
ence of either congenital or chromosomal fetal abnormalities, gestational or pre-gestational
diabetes, gestational hypertension, preeclampsia and signs of fetal hypoxia were excluded from
this study.
PPROM was diagnosed using a sterile speculum examination to verify the pooling of amni-
otic fluid and confirmed using a positive test for the presence of insulin-like growth factor-
binding protein 1 (Actim Prom test, Medix Biochemica, Kaunianen, Finland) in vaginal fluid
when necessary.
All women received prophylactic antibiotic treatment, and steroid therapy was administered
when PPROM occurred from 24–34 weeks of gestation. Tocolysis was administered for 48 h
during lung maturation.
The clinical guidelines of the Czech Republic recommends an active management of preg-
nancy when PPROM occurs later than 28 weeks of gestation. Labor is induced or Cesarean sec-
tion is performed after lung maturation within 72 h following membrane rupture in all
PPROM later than 28 weeks. The induction of labor or the performance of Cesarean section
was indicated based on signs of fetal distress and/or severe vaginal bleeding and/or clinical
chorioamnionitis or when high levels of maternal serum CRP were observed before 28 weeks.
The remaining women were treated expectantly up to completed 28 weeks of gestation.
Written informed consent was obtained from all subjects. The University Hospital Hradec
Kralove Institutional Review Board approved the collection and use of these samples and infor-
mation for research purposes (March 19, 2008; No. 200804 SO1P).
Maternal blood and amniotic fluids were collected prior to treatment with antibiotics, steroids
and tocolysis. Maternal blood was obtained via venipuncture of the cubital vein at admission.
Maternal serum CRP was measured using a high-sensitivity immunoturbidimetric analysis
(Modular PP analyzer, Roche, Basel, Switzerland), with a method sensitivity of 0.3 mg/L.
Amniotic fluid was obtained via ultrasound-guided transabdominal amniocentesis. Micro-
bial analyses of amniotic fluid were based on specific polymerase chain reaction (PCR) for
Ureaplasma species,Mycoplasma hominis and Chlamydia trachomatis and non-specific PCR
for 16S rRNA. MIAC was determined based on a positive result of the PCR analysis for
Maternal Serum CRP Levels and PPROM
PLOSONE | DOI:10.1371/journal.pone.0150217 March 4, 2016 3 / 16
Ureaplasma species,Mycoplasma hominis and Chlamydia trachomatis and/or positive 16S
rRNA gene amplification.
Placentas were collected after delivery and fixed in formalin, and tissue samples with placen-
tal membranes were embedded in paraffin. Tissue sections of placentas were stained using
hematoxylin and eosin for standard histological examination. HCA was defined using the Sala-
fia classification based on the presence of neutrophil infiltration in the chorion-decidua
(Grades 3–4) and/or the chorionic plate (Grades 3–4) and/or the umbilical cord (Grades 1–4),
and/or the amnion (Grades 1–4).[27]
Detection of Ureaplasma species,Mycoplasma hominis, and Chlamydia
trachomatis
DNA was isolated from amniotic fluid using a QIAamp DNAMini Kit (QIAGEN, Hilden, Ger-
many) according to the manufacturer’s instructions (using the protocol for the isolation of bac-
terial DNA from biological fluids). Real-time PCR was performed in a Rotor-Gene 6000
instrument (QIAGEN, Hilden, Germany) using the commercial kit AmpliSens1 C. trachoma-
tis/Ureaplasma/M. hominis-FRT (Federal State Institution of Science, Central Research Insti-
tute of Epidemiology, Moscow, Russia) to detect the DNA from Ureaplasma species,
Mycoplasma hominis, and Chlamydia trachomatis in a common PCR tube. We included a PCR
run for the housekeeping gene beta-actin as a control to examine the presence of PCR inhibi-
tors. The amount of Ureaplasma species DNA in copies/mL was determined using an absolute
quantification technique that employs an external calibration curve. Plasmid DNA (pCR4,
Invitrogen) was used to prepare the calibration curve [28, 29].
Detection of other bacteria in the amniotic fluid
Bacterial DNA was identified using PCR targeting of the 16S rRNA gene with the following
primers: 5`-CCAGACTCCTACGGGAGGCAG-3`(V3 region), 5`-ACATTTCACAACAC
GAGCTGACGA-3`(V6 region) [30, 31]. Each individual reaction contained 3 μL of target
DNA, 500 nM of forward and reverse primers and Q5 High-Fidelity DNA polymerase (NEB,
USA) in a total volume of 25 μL. The amplification was performed in a 2720 Thermal Cycler
(Applied Biosystems, Foster City, CA, USA). The products were visualized on an agarose gel.
Positive reactions yielded products of 950 bp, which were subsequently analyzed by sequenc-
ing. The 16S PCR products were cleaned and used in sequencing PCR reactions utilizing the
above primers and the BigDye Terminator kit, version 3.1. The bacteria were typed using the
sequences obtained in BLAST1 and SepsiTestTM BLAST.
Statistical analysis
All statistical analyses were performed using SPSS 21.0 for Mac OS X (SPSS Inc., Chicago, IL,
USA) and GraphPad Prism 6.0 for Mac OS X (GraphPad Software, La Jolla, CA, USA).
Demographic and clinical characteristics were compared using non-parametric Kruskal-
Wallis test, and data are presented as medians [interquartile range (IQR)]. Categorical variables
were compared using the Chi-square test and presented as numbers [percentage (%)]. Spear-
man partial correlation was used to adjust the data for gestational age at admission or delivery.
Spearman rank correlation test was used to determine the correlations between CRP concen-
trations and the microbial load of Ureaplasma species. Differences were considered statistically
significant at p< 0.05, and p-values were obtained from two-sided tests.
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Results
Clinical characteristics of the study population
A total of 495 pregnant women with PPROMmet the inclusion criteria and were included in
the present study. Sixty-eight women were excluded because of pre-gestational diabetes, gesta-
tional diabetes, chronic hypertension, gestational hypertension, preeclampsia or fetal growth
restriction in the fetus. Amniocentesis was not possible in 22 of the 427 women, and the results
of histopathological assessments of the placenta were not available for 19 women. The remain-
ing 386 women were included in the present study (Fig 1). Table 1 shows all microorganisms
identified in the amniotic fluid.
The presence of MIAC and HCA was observed in 25% (97/386) of women. The presence of
HCA or MIAC alone was observed in 36% (141/386) and 8% (32/386) of women, respectively.
The remaining 29% (116/386) of women had neither MIAC nor HCA.
Table 2 presents maternal and neonatal characteristics according to the presence and
absence of MIAC and/or HCA. The women with MIAC and HCA had the lowest gestational
Fig 1. Inclusion of womenwith PPROM.
doi:10.1371/journal.pone.0150217.g001
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age and the lowest birth weight at admission and delivery. Latency from PPROM to delivery,
gestational age at delivery and birth weight were not relevant clinical findings in this cohort of
women because of the active management after 28 weeks of gestation [32].
Table 1. Microorganisms identified in the amniotic fluid.
Microorganisms identiﬁed in the amniotic ﬂuid Number of
women
Ureaplasma species 78
Mycoplasma hominis 7
Ureaplasma species + Mycoplasma hominis 9
Ureaplasma species + Chlamydia trachomatis 5
Streptococcus agalactiae 4
Haemophilus inﬂuenza 3
Staphylococcus hominis 3
Streptococcus α haemolyticus 2
Ureaplasma species + Leptotrichia amnionii 2
Ureaplasma species + Sneathia sanguinegens 2
Biﬁdobacterium species 1
Candida albicans 1
Enterococcus faecalis 1
Enterococcus faecim + Candida crusei 1
Enterococcus faecium 1
Fusobacterium nucleatum 1
Granulicatella elegans 1
Chlamydia trachomatis + Leptotrichia amnionii 1
Mycoplasma hominis + Lactobacillus species 1
Mycoplasma hominis + Peptococcus species + Propionibacterium species
+ Bacteroides species
1
Peptococcus species + Propionibacterium species 1
Peptostreptococcus anaerobicus 1
Propionibacterium species + Peptostreptococcus species 1
Sneathia sanquinegens + Leptotrichia amnionii 1
Staphylococcus epidermidis 1
Staphylococcus haemofylus 1
Streptococcus anginosus 1
Streptococcus condemnatus 1
Streptococcus mitis 1
Streptococcus pneumoniae 1
Streptococcus species 1
Ureaplasma species + Fusobacterium nucleatum 1
Ureaplasma species + Lactobacillus crispatus 1
Ureaplasma species + Lactobacillus species 1
Ureaplasma species + Mycoplasma hominis + Fusobacterium nucleatum 1
Ureaplasma species + Staphylococcus auricularis 1
Ureaplasma species + Streptococcus oralis 1
Ureaplasma species + Veillonela species 1
doi:10.1371/journal.pone.0150217.t001
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Maternal serum CRP concentrations according to the presence or
absence of MIAC and/or HCA
Women with MIAC and HCA exhibited the highest concentration of CRP [median: 9.0 mg/L
(IQR: 3.9–20.1)] vs. women with HCA alone [median: 6.9 mg/L (IQR: 3.6–12.1)], MIAC alone
[median: 7.4 mg/L (IQR: 3.6–15.6)] or with neither MIAC nor HCA [median: 4.5 mg/L (IQR:
2.0–8.6)]; (Fig 2) in crude analysis (p< 0.0001) and after adjustment for the gestational age of
the sample (p< 0.0001).
Pregnancies with MIAC and HCA exhibited higher median CRP concentrations than
women with HCA alone, MIAC alone, and neither MIAC nor HCA.
Table 3 shows the predictive value of CRP levels to identify women with MIAC and HCA
below and above 32 weeks. Women with PPROM below 28 weeks were managed differently
than women with gestational age longer than 28 weeks. Therefore, we analyzed these sub-
groups of women separately. The predictive values of CRP levels remained weak (Table 4). We
examined the extreme values of CRP for the prediction of MIAC and HCA because the predic-
tive values of CPR were poor (Table 5). Figs 3 and 4 shows the extreme values as represented
by the 95th percentile below and above 32 weeks of gestation. Supplemental information of the
graphical distribution of CRP in the 90th percentile below and above 32 weeks is provided in S1
Fig and S2 Fig. The small sample size in the subgroup of women with gestation age below 28
weeks prevented us from analyzing the extreme values of CRP.
Table 2. Maternal and neonatal characteristics in the different subgroups of PPROM pregnancies from 24+4 to 36+6 weeks of gestation.
The presence of MIAC
and HCA(n = 97)
The presence of HCA
alone (n = 141)
The presence of MIAC
alone (n = 32)
The absence of MIAC
and HCA (n = 116)
p-value
Maternal age 31 (26–35) 32 (28–35) 31 (26–34) 30 (27–34) 0.13
Primiparous 33 (34%) 69 (49%) 17 (53%) 64 (55%) 0.02
Pre-pregnancy BMI 22.4 (20.1–25.1) 23.4 (21.1–26.3) 22.2 (19.6–24.2) 21.8(19.9–24.9) 0.01
Smoking 29 (30%) 21 (15%) 10 (31%) 15 (12%) 0.002
Gestational age at admission
(week+days)
30+5 (27+6–33+6) 32+4 (31+1–35+0) 34+0 (33+0–35+6) 33+1 (31+5–35+1) <0.0001
Gestational age at delivery
(week+days)
31+1 (28+1–33+6) 32+6 (31+4–35+1) 34+1 (33+0–35+6) 33+2 (32+0–35+2) <0.0001
Latency from PPROM to
amniocentesis (h)
7 (4–12) 6 (4–11) 4 (3–6) 6 (3–10) 0.002
Latency from PPROM to
delivery (h)
46 (24–83) 40 (22–76) 17 (9–51) 31 (14–63) 0.001
CRP levels at admission
(mg/L)
9.0 (3.9–20.1) 6.4 (3.5–9.9) 4.3 (2.1–9.3) 4.5 (2–8.5) <0.0001
WBC count ad admission
(x109/L)
13.1 (11.0–15.5) 11.7 (9.0–13.0) 11.7 (10.1–14.8) 12.0 (10.0–14.6) 0.46
Induction of labor 42 (43%) 37 (26%) 14 (44%) 29 (25%) 0.006
Vaginal delivery 69 (71%) 91 (65%) 26 (81%) 81 (70%) 0.29
Birth weight (grams) 1720 (1155–2125) 2080 (1640–2455) 2235 (1838–2518) 2280 (1748–2565) <0.0001
5 min Apgar score < 7 10 (10%) 8 (6%) 0 (0%) 3 (3%) 0.06
10 min Apgar score < 7 6 (6%) 3 (2%) 0 (0%) 2 (2%) 0.13
Abbreviations: PPROM: preterm prelabor rupture of membranes. MIAC: microbial invasion of amniotic cavity. HCA: histological chorioamnionitis. BMI:
body mass index. CRP: C-reactive protein. WBC: white blood cell. Continuous variables were compared using a non-parametric Kruskal Wallis test, and
results are presented as medians (interquartile range). Categorical variables were compared using the Chi-square test and presented as numbers (%).
Statistically signiﬁcant differences are indicated in bold.
doi:10.1371/journal.pone.0150217.t002
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Maternal serum CRP in women with genital mycoplasmas and other
microorganisms in the amniotic fluid
No differences in maternal CRP concentrations were observed between women infected with
genital mycoplasmas (Ureaplasma species and/or Mycoplasma hominis) [median: 6.6 mg/L
(IQR: 3.5–12.1)] and women infected with other microorganisms [median: 7.1 mg/L (IQR:
2.63–14.2) p = 0.81].
Fig 2. Maternal serumCRP concentrations (medians) according to subgroups of women with PPROM.Maternal serum C-reactive protein (CRP)
concentrations according to the presence and absence of microbial invasion of the amniotic cavity (MIAC) and/or histological chorioamnionitis (HCA).
doi:10.1371/journal.pone.0150217.g002
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Maternal CRP concentrations and the bacterial load of Ureaplasma
species
A positive correlation between the microbial burden of Ureaplasma species in the amniotic
fluid and maternal CRP concentrations was found (Spearman r = 0.33, p = 0.002; Fig 5).
Microbial load of Ureaplasma species according to the presence of MIAC
alone or MIAC and HCA
The amount of Ureaplasma species in amniotic fluid was determined in women who exhibited
positive PCR for Ureaplasma species (70 women with MIAC and HCA and 16 women with
MIAC alone). Women with MIAC and HCA (n = 70) had a higher microbial load of Urea-
plasma species in amniotic fluid compared to women with MIAC alone (n = 16) [MIAC and
HCA [median: 465000 (IQR): 3700–6667000)] vs. MIAC alone [median: 9333 (IQR: 597–
235000), p< 0.005]].
Discussion
The main finding of the present study was the weak association between maternal serum CRP
and the occurrence of MIAC and HCA, even when different gestational ages were considered.
Only CRP levels above the 95th percentile in PPROM below 32 weeks of gestation accurately
predicted the occurrence of MIAC and HCA. Unfortunately, this low sensitivity prevents the
application of this finding in a clinical setting.
The worst scenario in PPROM is the presence of MIAC and HCA [4, 11, 33]. We demon-
strated that the presence of MIAC and HCA represented the condition with the highest inflam-
matory response in the amniotic cavity and fetal compartment [12, 13]. However, the only
method to diagnose MIAC is an invasive procedure, and histopathological information of
HCA is not available antenatally. Therefore, the present study focused on the prediction of
MIAC and HCA using a non-invasive approach, which involved the determination of a classi-
cal marker of infection, maternal serum CRP.
Previous studies reported the influence of CRP in pregnancies complicated with HCA[26]
[34] [19], but few studies focused on the relationship with MIAC [24]. Howman et al. observed
a significantly higher maternal inflammatory response when evaluating CRP in women with
HCA[26]. The study population also included women with clinical chorioamnionitis. There-
fore, the differences in CRP could partially reflect the inclusion of women with severe and late
stage infections, when the maternal inflammatory response is primarily activated [35].
Table 3. Predictionmodel for the presence of microbial invasion of the amniotic cavity and histologi-
cal chorioamnionitis in PPROM below/above 32 weeks of gestation.
Gestational age < 32+0 (n = 140) Gestational age  32+0(n = 246)
Model CRP > 6.45 mg/L CRP > 6.95 mg/l
AUC 0.66 0.64
Sensitivity 63.1% 61.5%
Speciﬁcity 56.6% 62.6%
PPV 50.0% 24.0%
NPV 69.1% 90.5%
LR + 1.46 1.65
Abbreviations: AUC: Area under the curve. PPV: Positive predictive value. NPV: Negative predictive value.
LR+: Positive Likelihood ratio.
doi:10.1371/journal.pone.0150217.t003
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Contrary to Howman et al. and Laar et al., the inclusion of women with clinical chorioamnio-
nitis did not exhibit differences when the role of CRP was evaluated to detect HCA [34]. Simi-
larly, Martinez et al. conducted a review based on the evaluation of eight studies and did not
observe data to support an influence of CRP on HCA [19]. A lack of association was also
observed when evaluating maternal serum CRP between PPROM women with or without
MIAC [24]. Nephelometry, turbidimetry with standard sensitivity[19, 34] and high sensitivity
CRP nephelometry with lower limits of detection below 1.0 mg/L[26] were used to measure
CRP. The variation in CRP results must be expected when different analytical techniques for
CRP evaluation are used Nevertheless, it is unlikely that these variations affected the results of
these studies [36].
Therefore, the data obtained in the present study revealed differences in CRP levels between
different infectious subgroups of women with PPROM. CRP concentrations are gestational
age-dependent[37], and differences in gestational age at sampling were observed between
groups. Therefore, we adjusted the CRP concentrations for this confounding factor. CRP
remained significantly higher in the subgroup of women with MIAC and HCA after adjusting
by gestational age at sampling. However, the predictive value of CRP to identify the worst
infectious scenario was weak, even at early gestational ages. We considered the extreme values
represented by the 90th and 95th percentile to further explore the predictive value of CRP in a
secondary analysis. The results demonstrated that a PPV of 90%, a FP rate of 1% and a +LR
ratio of 13.1 predicted MIAC and HCA only when CRP levels were above the 95th percentile
Table 4. Predictionmodel for the presence of microbial invasion of the amniotic cavity and histological chorioamnionitis in PPROM based on the
gestational age subgroups.
Gestational age 24+0–28+0 (n = 50) Gestational age 28+1–31+6 (n = 90) Gestational age 32+0–36+6 (n = 246)
Model CRP > 7.7 mg/L CRP > 6.40 mg/L CRP > 6.95 mg/l
AUC 0.70 0.62 0.64
Sensitivity 68.0% 60.0% 61.5%
Speciﬁcity 68.0% 52.4% 62.6%
PPV 68.0% 42.0% 24.0%
NPV 68.0% 68.9% 90.5%
LR + 2.12 1.25 1.65
Abbreviations: AUC: Area under the curve. PPV: Positive predictive value. NPV: Negative predictive value. +LR: Positive Likelihood ratio.
doi:10.1371/journal.pone.0150217.t004
Table 5. Predictionmodel for the presence of microbial invasion of the amniotic cavity and histological chorioamnionitis in PPROM below/above
32 weeks of gestation using extreme CRP values.
Gestational age < 32+0
(n = 18)
Gestational age < 32+0
(n = 10)
Gestational age  32+0
(n = 21)
Gestational age  32+0
(n = 9)
CRP cutoff
levels
90th percentile 21.6 mg/L 95th percentile 34.7 mg/L 90th percentile 21.6 mg/L 95th percentile 34.7 mg/L
AUC 0.66 0.66 0.64 0.64
Sensitivity 22.8% 15.8% 17.5% 6.5%
Speciﬁcity 94.0% 98.8% 93.2% 97.0%
PPV 72.0% 90.0% 33.3% 33.3%
NPV 64.8% 63.1% 85.3% 82.3%
+ LR 3.8 13.1 2.6 2.2
Abbreviations: AUC: Area under the curve. PPV: Positive predictive value. NPV: Negative predictive value. +LR: Positive Likelihood ratio.
doi:10.1371/journal.pone.0150217.t005
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and only PPROM below 32 weeks even when the extreme values of CRP were considered.
However, the extremely low detection rate of 15% limits the clinical usefulness of this screening
technique. These findings reveal that assessment of CRP levels was a poor predictor of MIAC
and HCA, which highlights the importance of considering the amniocentesis as the only accu-
rate method to identify this infectious condition. Therefore, these findings are interesting and
clinically relevant.
Our previous study clearly demonstrated that the intraamniotic inflammatory response
depended on the microbial load of Ureaplasma species. No differences were observed between
the intensity of intraamniotic inflammatory response triggered by genital mycoplasmas and
other microorganisms[38, 39]. The present study revealed an association between maternal
CRP and the amount of Ureaplasma species in the amniotic fluid. We also did not observe dif-
ferences in the intensity of maternal CRP between women with genital mycoplasma and other
microorganisms. This finding is not consistent with Oh et al., who observed a higher inflam-
matory response in the amniotic cavity and maternal compartment in women with MIAC
compared to the presence of genital mycoplasmas and other microorganisms[40]. These con-
flicting results may reflect the different methodologies used to identify bacteria in the amniotic
fluid. Oh et al. used cultivation approaches in combination with the non-cultivation techniques
(specific and non-specific PCRs) that were used in the present study.
One of the strengths of the present study is the active management of PPROM in our
cohort, in which most women delivered within 72 h from membrane rupture. This
Fig 3. Maternal serumCRP concentrations (> 95th percentile) based on the presence and absence of MIAC and/or HCA in PPROM < 32 weeks of
gestation.Maternal serum C-reactive protein (CRP) concentrations (> 95 percentile) based on the presence and absence of microbial invasion of the
amniotic cavity (MIAC) and/or histological chorioamnionitis (HCA) in women with PPROM below 32 weeks of gestation.
doi:10.1371/journal.pone.0150217.g003
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management provides information on the placenta, which is consistent with the information
obtained from amniotic fluid analyses. We also obtained microbial results from the amniotic
fluid using modern non-cultivation technologies with a higher detection rate than classical cul-
tivation approaches. We explored a large cohort of women in one tertiary center hospital with
a clearly defined PPROM phenotype.
However, the present study also has some limitations. Maternal serum CRP analysis was
performed only at admission, and we were unable to longitudinally analyze the progression of
this protein until delivery. We also did not have information on IL-6 levels in amniotic fluid.
Therefore, we could not evaluate the influence of maternal CRP on the intra-amniotic inflam-
matory response.
In conclusion, maternal CRP was a poor predictor for the identification of women with
MIAC and HCA. Therefore, only the extreme cutoff levels of CRP, represented by the 95th per-
centile, predicted the presence of MIAC and HCA below 32 weeks of gestation. However, the
low sensitivity limits the clinical utility of this detection method. Therefore, there is no evidence
to support the use of CRP as a tool for the prediction of the presence of MIAC and HCA, and
the results suggest that amniocentesis is the most accurate tool for MIAC and HCA prediction
in women with PPROM.
Fig 4. Maternal serumCRP concentrations (> 95th percentile) based on the presence and absence of MIAC and/or HCA in PPROM > 32 weeks of
gestation.Maternal serum C-reactive protein (CRP) concentrations (> 95 percentile) based on the presence and absence of microbial invasion of the
amniotic cavity (MIAC) and/or histological chorioamnionitis (HCA) in women with PPROM above 32 weeks of gestation.
doi:10.1371/journal.pone.0150217.g004
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Fig 5. Correlation betweenmicrobial burden of Ureaplasma species in the amniotic fluid (copies DNA/mL) andmaternal CRP concentrations.
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